🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect on Periodontal Phenotype of Flapless Piezoincission During Orthodontic Treatment

RecruitingNAAges 16 Years - 70 YearsAllUniversidad Complutense de Madrid
NCT06315348 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Research Question While the reduction in treatment times and the patient satisfaction after periodontally accelerated osteogenic orthodontics (PAOO) are well sustained in the scientific literature, there is still controversy regarding if grafting leads to i) change of the periodontal phenotype and ii) greater stability of post-orthodontic treatment outcomes, highlighting the need of controlled clinical trials. Aims of the Project The aim of this randomized clinical trial (RCT) is to compare piezocision-assisted orthodontics, concomitant to soft tissue grafting (volume-stable collagen matrix), with piezocision-assisted orthodontics, concomitant to bone grafting with a xenograft and a native collagen membrane, in orthodontic non-growing patients. The primary aim will be to determine the impact of this surgical protocol on the hard and soft tissue changes occurring on the buccal aspect o

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients will be consecutively selected among those attending the Faculty of Odontology, University Complutense (Madrid, Spain) looking for orthodontic therapy. The inclusion criteria will be as follows: * patients requiring maxillary and/or mandible orthodontic treatment; * patients with permanent dentition in stage 5 or 6 of the cervical vertebral maturation method as described by Baccetti et al. (2002); * minimal to moderate maxillary and/or mandibular anterior crowding at baseline (arch length discrepancy from 3-8 mm); and * adequate oral health (i.e. periodontal health, absence of periapical infections and untreated caries). Exclusion Criteria: * subjects with periodontitis stage III or IV (Papapanou et al., 2018); * subjects with poor oral hygiene (represented as full-mouth plaque scores (FMPS) \>25%); * ongoing chronic drug therapy influencing bone metabolism (e.g. steroids, immunosuppressors or antiresorptive drugs); * subjects with uncontrolled systemic diseases (e.g. diabetes); * pregnancy and * subjects not willing to comply with the study visits
💊

What it tests

  • flapless alveolar decortication with augmentation
📍

Where

1 site
Faculty of Odontology, University Complutense Madrid
Madrid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy